The Regulator

20.8 million: that is the number of Original Medicare enrollees eligible for a one-time $90 Part B premium rebate that began reaching bank accounts around October 8, about $1.9 billion drawn from the Medicare Improvement Fund. The Centers for Medicare and Medicaid Services (CMS) says most recipients get a Social Security Administration deposit, while people without direct deposit get a Treasury check later in October labeled “Medicare Improvement Fund Payment.” Medicare Advantage enrollees, people whose premiums Medicaid pays, and higher earners who pay the Income-Related Monthly Adjustment Amount are excluded. The so-what: KFF projects the 2027 standard Part B premium will rise by $79, which nearly erases the $90, and the payment status line at the Social Security Administration opens October 15. Confidence: High on eligibility and timing, Medium on the dollar total, which is our arithmetic (20.8 million x $90). Sources: White House fact sheet, CMS rebate FAQ. Supplemental: KFF analysis.

Michigan’s attorney general sued Blue Cross Blue Shield of Michigan in federal court October 8, alleging an illegal monopoly that overcharged the state’s own employee health plan. The complaint, filed in the U.S. District Court for the Eastern District of Michigan, alleges the insurer controls 65 percent of the state’s commercial market and 79 percent of its preferred provider organization (PPO) market, and that other Blue plans refused to bid against it for the state employee contract. It asserts two Sherman Act counts, four Michigan Antitrust Reform Act counts, public nuisance and unjust enrichment. The insurer says it was “blindsided” and has not been served. These are allegations, not findings; prior Blue Cross Blue Shield Association class settlements totaled $2.7 billion with consumers and $2.8 billion with providers. Confidence: Medium (complaint not independently reviewed this run). Sources: Michigan Attorney General press release. Supplemental: Michigan Advance, Fierce Healthcare.

CMS announced October 9 that Iowa will receive more than $209 million and Louisiana $37.7 million from the Rural Health Transformation Program, part of the $50 billion national fund created by the 2025 reconciliation law. Iowa’s money, which the state has committed in full, funds robotic-assisted orthopedic surgery at rural hospitals, the state’s first Maternal-Fetal Medicine Telehealth Network, cancer screening hubs and emergency medical services technology. CMS says seven equipment installations have supported 44 advanced procedures so far and health information exchange tools connect more than 100 facilities. Louisiana’s $37.7 million is aimed at training and recruiting rural health care workers. The so-what for hospital operators: states are now turning awards into vendor and hiring spend, and CMS is publicizing results state by state. Confidence: High on amounts, Medium on how fast the money converts to contracts. Sources: CMS Iowa announcement, CMS Louisiana announcement.

The Food and Drug Administration (FDA) has flagged four deaths among patients given the schizophrenia drug evenamide as a potential cardiac safety signal, and the U.S. clinical hold on the drug’s phase 3 trial stays in place, drugmaker Newron disclosed October 8. Wire reporting says four patients who received evenamide across studies died, versus one on placebo, and FDA could not exclude a fatal arrhythmia mechanism. Newron says investigators judged three unrelated and one possibly related, and that enrollment in the ENIGMA-TRS 2 trial continues outside the United States. The hold dates to April 2026. FDA’s letter and Newron’s October filing were not retrieved this run, so the primary document is not yet posted here. Confidence: Low (per reporting; primary document not retrieved). Sources: Newron regulatory news on the April enrollment pause. Supplemental: KSL wire report.

Wisconsin’s public comment window on a Medicaid waiver to cover health care in jails and prisons before release runs through October 31, with a virtual hearing October 14, as CMS has newly approved the same model in Louisiana, Minnesota and Nevada. The three approvals each run October 1, 2026 through September 30, 2031 and let Medicaid pay for services in the weeks before release despite the federal “inmate exclusion.” Louisiana’s covers up to 60 days before release, Nevada’s reaches youth facilities for up to 90 days, and Wisconsin proposes up to 90 days including case management, medication for opioid use disorder and a 30-day prescription supply on release day. Manatt counts 22 states plus the District of Columbia with reentry approvals. Confidence: High on dates and windows, Medium on the 22-state count (law-firm tally). Sources: Medicaid.gov Louisiana reentry approval, Medicaid.gov Minnesota approval, Medicaid.gov Nevada approval, Wisconsin Department of Health Services public notice. Supplemental: Manatt Health.